Abzena subsidiary Antitope, INSERM and Baylor Institute for Immunology Research to collaborate to produce manufacturing cell lines for two vaccines for HIV
14-Jan-2015 -
Abzena plc announced its wholly-owned subsidiary Antitope Limited has extended its relationship with INSERM, ANRS and the Baylor Institute for Immunology Research (“BIIR”.INSERM-ANRS and the BIIR have developed innovative approaches for HIV vaccines targeting HIV antigens to dendritic cells (DC) ...
HIV
vaccines